Home
Demo
Sample
Subscription
Contact Us
Sign In

Home
Demo
Sample
Subscription
Contact Us
Sign In

Home
Demo
Sample
Subscription
Contact Us
Sign In

Schedule a Demo

Analysts at Intellishots

Custom IntelliShots

Demo

30 min

Calendar is loading...

Powered by Booking Calendar

First Name*:

Last Name*:

Email*:

Phone:

Time Slots*:

Details:

2nd Floor,

123 Kakrola Complex

Sector 15 Dwarka

Dwarka Mor, New Delhi,

INDIA - 110075

To discuss how we can support you, please get in touch via:

intellishots@octavusconsulting.com

Sample Newsalerts

AbbVie Signs a Partner and Option to Acquire Agreement with TeneoOne for its TNB-383B
Roche Reports Results of Venclexta/Venclyxto (venetoclax) in P-III CLL14 Study for CLL
BeiGene and SpringWorks Globally Signs Clinical Agreement to Target Advanced Solid Tumours
AbbVie Reports FDA’s Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma
Roche to Acquire Spark Therapeutics for $4.3B

Latest Tweets

Octavus ConsultingFollow

Retweet on Twitter Octavus Consulting Retweeted

PharmaShots - Incisive news in 3 shots @Pharmashot·

PharmaShots Weekly Snapshot (Sept 14 -18, 2020) @Pharmashot
https://pharmashots.com/48796/pharmashots-weekly-snapshot-sept-14-18-2020/

Reply on Twitter 1306957331201097728 Retweet on Twitter 13069573312010977282 Like on Twitter 1306957331201097728 Twitter 1306957331201097728

Contact Us

Name *

Email *

Comment or Message *

Message

Copyright ©2020 IntelliShots | A CI solution from Octavus Consulting